CClinicalTrials.gg
RecruitingNCT06553989MOVENDOPUpdated Feb 4, 2025

Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery

An interventional study of osteopatic visceral mobilization in Endometriosis and Osteopathy in Diseases Classified Elsewhere, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-04.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.

02

Conditions studied

  • Endometriosis
  • Osteopathy in Diseases Classified Elsewhere

Browse trials for

03

In context

Endometriosis

901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.

This study's planned enrollment of 63 is close to the median of 64 across 525 interventional studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Woman of legal age
  • Indication for surgery for infiltrating endometriosis
  • Able to give informed consent to participate in research
  • Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital)

Exclusion criteria

Exclusion Criteria:

  • Indication for surgery for superficial endometriosis
  • Patient of legal age, under guardianship or trusteeship
  • Pregnant or breast-feeding patient
  • Patients not affiliated to the social security system
  • Patients who do not speak French
  • Patients under court protection
  • Simultaneous participation in another study
  • Refusal to participate.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
63 participants (estimated)

Study arms

  • No intervention
    Control group

    patients operated for endometriosis without osteopathic visceral mobilization

  • Experimental
    Experimental group

    patients operated for endometriosis with osteopathic visceral mobilization

    Other: osteopatic visceral mobilization

Interventions

  • Otherosteopatic visceral mobilization

    a combination of breathing and visceral mobilizations

06

What researchers measure

Primary outcomes

  1. Quality of life with the EHP-30 questionnaire score

    Percentage change in baseline questionnaire score (EHP-30) between pre-operative visit and 1 year. The EHP-30 contains 30 items and ranges from 0 (best health) to 100 (worst health). The items in the baseline questionnaire are grouped into 5 main sub-domains: pain, control and powerlessness, emotional well-being, social support and self-image.

    Time frame: 1 year

Secondary outcomes

  1. quality of life with score of the questionnaire EHP-30

    Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations

    Time frame: pre-operative, 6 months and 12 months

  2. quality of life with score of the questionnaire GIQLI

    Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations

    Time frame: pre-operative, 6 months and 12 months

  3. quality of life with score of the questionnaire FSFI

    Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations

    Time frame: pre-operative, 6 months and 12 months

  4. quality of life with score of the questionnaire ICIQ-FLUTS

    Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations

    Time frame: pre-operative, 6 months and 12 months

  5. quality of life with score of the questionnaire PCS

    Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations

    Time frame: pre-operative, 6 months and 12 months

  6. pelvic pain

    Compare pelvic pain between the 2 groups using EVA Scale (Visual Analogic Scale (from 0 : no pain to 10 : worst pain possible)

    Time frame: pre-operative, 6 hours after surgery, 1 day after surgery, 1 month after surgery, 6 months and 12 months

  7. quality of life with the sub-domains of the EHP-30 questionnaire

    Compare changes in patients' quality of life between the 2 groups regarding the sub-domains the EHP-30 questionnaire

    Time frame: pre-operative, 6 months and 12 months

  8. evaluation of the cicatrisation

    Examination of scar appearance by the surgeon : acquired healing, healing in progress or disunion

    Time frame: post operative, 6 months and 12 months

  9. evaluation of the abdominal flexibility

    Evaluation of abdominal flexibility with an EVA scale in the regions: right and left iliac fossa, hypogastrium at one year assessed by an independent osteopath between 0 and 10 (0 corresponding to normal flexibility and 10 to total rigidity).

    Time frame: 1 year

  10. Use of additional care

    Compare the use of additional care between the 2 groups by collecting data on the type of consultations (gynecologist, general practitioner, midwife, pain center doctor, emergency doctor, osteopath, physiotherapist, acupuncturist, magnetizer, hypnotherapist, healer, ...) and the number of visits

    Time frame: 1 year

  11. consumption of analgesics and hormonal treatment

    Compare the consumption of analgesics and hormonal treatment (name and dose of the medication) between the 2 groups

    Time frame: 1 year

  12. fertility

    Achieving pregnancy during the first postoperative year (yes or no)

    Time frame: 1 year

  13. number of days of sick leave

    Compare the number of days of sick leave between the two groups

    Time frame: 1 year

  14. compare patient profiles using the sub-domains of the EHP-30 questionnaire

    In the experimental group, identify patient profiles based on the sub-domains of quality of life assessed during the pre-operative visit, and compare these different groups according to the improvement in patients' post-operative quality of life at one year.

    Time frame: 1 year

  15. patient compliance

    evaluate the impact of compliance of patients in the visceral mobilization group on improved quality of life and abdominal flexibility (by collecting the number of osteopathic self-mobilizations performed each month following surgery and during1 year)

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    • Lise Laclautre · Contact
    • Nicolas Bourdel · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06553989
Lead sponsor
University Hospital, Clermont-Ferrand
Responsible party
Sponsor
First posted
Aug 14, 2024
Start date
Jan 27, 2025
Primary completion
Sep 2027 (estimated)
Completion
Sep 2028 (estimated)
Last update
Feb 4, 2025

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334.73.754.963
Nicolas Bourdel
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion